Gestonorone
| | |
| Gestonorone
| |
| Systematic (IUPAC) name | |
| (8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy- 13-methyl-1,2,6,7,8,9,10,11,12,14,15,16- dodecahydrocyclopenta[a]phenanthren-3-one | |
| Identifiers | |
| CAS number | ? |
| ATC code | G03 L02AB03 |
| PubChem | |
| Chemical data | |
| Formula | C20H28O3 |
| Mol. mass | 316.435 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
|
WikiDoc Resources for Gestonorone | |
|
Articles | |
|---|---|
|
Most recent articles on Gestonorone Most cited articles on Gestonorone | |
|
Media | |
|
Powerpoint slides on Gestonorone | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Gestonorone at Clinical Trials.gov Clinical Trials on Gestonorone at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Gestonorone
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Gestonorone Discussion groups on Gestonorone Patient Handouts on Gestonorone Directions to Hospitals Treating Gestonorone Risk calculators and risk factors for Gestonorone
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Gestonorone | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Gestonorone is a progestagen hormone.
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies